These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24400369)

  • 1. Author's reply: To PMID 23228972.
    Akkaya H; Karakaş MS
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):721. PubMed ID: 24400369
    [No Abstract]   [Full Text] [Related]  

  • 2. Can nebivolol be helpful in Behçet's disease?
    Tommasino A; Mauro GB
    Anadolu Kardiyol Derg; 2013 Mar; 13(2):121-2. PubMed ID: 23228973
    [No Abstract]   [Full Text] [Related]  

  • 3. Flow-mediated dilatation measurement as a simple practical method in Behçet's diseases without cardiovascular involvement.
    Balta I; Balta S; Demirkol S; Küçük U; Aydın E
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):720-1. PubMed ID: 24172801
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of nebivolol on endothelial dysfunction in patients with Behçet's disease; a prospective single-arm controlled study.
    Akkaya H; Sahin O; Borlu M; Oğuzhan A; Karakaş MS
    Anadolu Kardiyol Derg; 2013 Mar; 13(2):115-20. PubMed ID: 23228972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?".
    Balligand JL
    J Am Coll Cardiol; 2009 Apr; 53(17):1539-42. PubMed ID: 19389565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endothelioprotective properties of L-arginine in a nitric oxide deficiency model].
    Pokrovskiĭ MV; Pokrovskaia TG; Kochkarov VI; Artiushkova EB
    Eksp Klin Farmakol; 2008; 71(2):29-31. PubMed ID: 18488903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery.
    Georgescu A; Pluteanu F; Flonta ML; Badila E; Dorobantu M; Popov D
    Eur J Pharmacol; 2005 Jan; 508(1-3):159-66. PubMed ID: 15680267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional and biochemical characteristics of the vasodilator effects of nebivolol in patients with arterial hypertension].
    Gel'tser BI; Kotel'niko v VN; Savchenko SV
    Ter Arkh; 2002; 74(12):34-7. PubMed ID: 12577837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.
    Lekakis JP; Protogerou A; Papamichael C; Vamvakou G; Ikonomidis I; Fici F; Mavrikakis M
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):277-81. PubMed ID: 16187009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerivastatin and endothelial function in elderly patients with diabetes mellitus.
    Stein JH; Carlsson CM
    Circulation; 2002 Jan; 105(4):E32-3. PubMed ID: 11815445
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilator effects of nebivolol in a rat model of hypertension and a rabbit model of congestive heart failure.
    de Groot AA; Mathy MJ; van Zwieten PA; Peters SL
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):56-60. PubMed ID: 17666916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial wall characteristics in patients with Adamantiades-Behçet's disease.
    Protogerou A; Lekakis J; Stamatelopoulos K; Aznaouridis K; Karatzis E; Ikonomidis I; Papamichael Ch; Markomihelakis N; Mavrikakis M; Kaklamanis PG
    Adv Exp Med Biol; 2003; 528():399-404. PubMed ID: 12918733
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of nebivolol on P wave duration and dispersion in patients with coronary slow flow.
    Güneş Y; Tuncer M; Güntekin U; Ceylan Y
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):290-5. PubMed ID: 19666430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nebivolol on endothelial function in obese patients with hypertension].
    Kovaleva ON; Demidenko AV
    Lik Sprava; 2006 Jun; (4):57-61. PubMed ID: 17100242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5 HT1A-receptors.
    Chlopicki S; Kozlovski VI; Gryglewski RJ
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):615-24. PubMed ID: 12512696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation.
    Kubli S; Feihl F; Waeber B
    Clin Pharmacol Ther; 2001 Apr; 69(4):238-44. PubMed ID: 11309552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
    J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries.
    Wang Y; Zhang M; Liu Y; Li J; Song E; Niu L; Cheng N
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):332-8. PubMed ID: 19903983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
    Cockcroft JR; Chowienczyk PJ; Brett SE; Chen CP; Dupont AG; Van Nueten L; Wooding SJ; Ritter JM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1067-71. PubMed ID: 7562470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.